“…[1] Complications of replacement therapy with rFVIIa include thrombosis and production of antibodies against FVII, usually seen with the frequent and large dose infusion. [4] Measurement of FVII activity and PT-INR is helpful for preventing overdose administration. Maintaining FVII level of at least 15%-25% provides adequate haemostatic level for most surgical procedures.…”